Table 1.
Baseline patient characteristics
| Baseline characteristic | s.c. 1400 mg (n = 16)* | s.c. 1600 mg (n = 17)† | s.c. 1870 mg (n = 22)‡ |
|---|---|---|---|
| Median age, years (range) | 57.5 (38–77) | 61.0 (45–72) | 58.5 (43–67) |
| Age category, n (%) | |||
| <65 years | 13 (81) | 10 (59) | 20 (91) |
| 65–70 years | 2 (13) | 6 (35) | 2 (9) |
| >70 years | 1 (6) | 1 (6) | – |
| Gender, n (%) | |||
| Male | 10 (63) | 15 (88) | 15 (68) |
| Female | 6 (38) | 2 (12) | 7 (32) |
| Race, n (%) | |||
| White | 16 (100) | 14 (88) | 22 (100) |
| American Indian/Alaska | – | 1 (6) | – |
| Native | – | 1 (6) | – |
| Other | |||
| Hispanic ethnicity, n (%) | 3 (19) | 4 (27) | 1 (5) |
| BSA (m2), median (range) | 1.89 (1.60–2.35) | 1.98 (1.63–2.40) | 1.91 (1.56–2.13) |
| Median time from first CLL diagnosis, months (range) | 8.2 (0.3–95.9) | 10.8 (0.7–141.4) | 20.3 (4.0–101.1) |
| Binet stage | |||
| A | 5 (31) | 4 (24) | 5 (23) |
| B | 10 (63) | 8 (47) | 14 (64) |
| C | 1 (6) | 5 (29) | 3 (14) |
BSA, body surface area; CLL, chronic lymphocytic leukaemia; sc, subcutaneous.
*n = 15 for BSA.
†n = 15 for Hispanic ethnicity and n = 16 for race.
‡n = 21 for Hispanic ethnicity.